OTE Readership Survey 2007
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
How a newly defined category of IOLs can benefit patient outcomes
A new functional classification can help achieve precise vision goals
PHOTON Results and Their Relation to DME Patients in Your Practice
John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.
Iridex enrolls first patient in study evaluating MicroPulse technology as an adjunct to anti-VEGF therapy for DME
The study will be led by principal investigator professor Noemi Lois, MD, PhD, FRCS(Ed), FRCOphth, at Queen’s University Belfast, in over 20 clinical sites, and plans to enroll 264 patients across the UK with severe DME.
PULSAR Results and Their Relation to nAMD Patients in Your Practice
John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.
Three-year outcomes of aflibercept 8mg in neovascular age related macular degeneration and diabetic macular edema
Myopia’s global impact, by the numbers
The global prevalence of myopia has surged, and is expected to affect nearly 5 billion people by 2050